Syngenta Korea Registers First Fungicide 'Mirae Bit' for Soybean Wilt and Mummy Disease

Published Jul 15, 2025

Tridge summary

[Korea Agricultural and Fishery Newspaper, Reporter Kim Young-min] Syngenta Korea has registered 'Mirae-bit' (product name: Pidiflumethopen water-dispersible liquid) as the country's first fungicide for soybean wilt disease and mummy disease. Wilt disease is a soil-borne pathogenic disease where infected plants show symptoms of rotting vascular tissue in the stem and stunted growth. Mummy disease is transmitted from infected plant tissue or seeds where mycelium overwinters, and can quickly invade in humid environments, making control difficult and having strong pathogen survival capabilities. These wilt and mummy diseases occur in various crops but can particularly cause simultaneous reduction in yield and quality when occurring in soybean cultivation

Original content

Syngenta Korea has registered 'Mirae Bit' (product name: Pidiflumethopen Liquid Flowable) as the country's first fungicide for soybean wilt disease and mummy disease. Wilt disease is a soil-borne disease where infected plants show symptoms of rotting vascular bundles in the stem and stunted growth. Mummy disease is transmitted when mycelium overwinters in diseased plant tissues or seeds, and can quickly invade in humid environments, making it difficult to control and having strong pathogen survival. These diseases occur in various crops but can particularly cause significant yield and quality reduction in soybeans, making early control essential. However, until now, there have been no registered control agents for these soybean diseases in Korea, leaving farmers without effective solutions. Accordingly, Pidiflumethopen is the only active ingredient registered for soybean wilt and mummy diseases, and its representative product Mirae Bit is expected to provide an effective solution ...
Source: Agrinet

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.